New Gram-positive agents in nosocomial infection

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)593-598
Number of pages6
JournalCurrent Opinion in Infectious Diseases
Volume13
Issue number6
StatePublished - 2000

Fingerprint

Linezolid
Cross Infection
Methicillin Resistance
Coagulase
Methicillin-Resistant Staphylococcus aureus
Staphylococcus
Therapeutics
quinupristin-dalfopristin
Vancomycin-Resistant Enterococci

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

New Gram-positive agents in nosocomial infection. / Patterson, Jan E.

In: Current Opinion in Infectious Diseases, Vol. 13, No. 6, 2000, p. 593-598.

Research output: Contribution to journalArticle

@article{d3f5655bd09f419fbc1c4e3eed8e082e,
title = "New Gram-positive agents in nosocomial infection",
abstract = "Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.",
author = "Patterson, {Jan E}",
year = "2000",
language = "English (US)",
volume = "13",
pages = "593--598",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - New Gram-positive agents in nosocomial infection

AU - Patterson, Jan E

PY - 2000

Y1 - 2000

N2 - Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.

AB - Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.

UR - http://www.scopus.com/inward/record.url?scp=0033673071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033673071&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033673071

VL - 13

SP - 593

EP - 598

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 6

ER -